New Anti-Cancer Strategy to Suppress Colorectal Cancer Growth Through Inhibition of ATG4B and Lysosome Function

Cancers
Yuanyuan FuMin Li

Abstract

Autophagy inhibition has been proposed to be a potential therapeutic strategy for cancer, however, few autophagy inhibitors have been developed. Recent studies have indicated that lysosome and autophagy related 4B cysteine peptidase (ATG4B) are two promising targets in autophagy for cancer therapy. Although some inhibitors of either lysosome or ATG4B were reported, there are limitations in the use of these single target compounds. Considering multi-functional drugs have advantages, such as high efficacy and low toxicity, we first screened and validated a batch of compounds designed and synthesized in our laboratory by combining the screening method of ATG4B inhibitors and the identification method of lysosome inhibitors. ATG4B activity was effectively inhibited in vitro. Moreover, 163N inhibited autophagic flux and caused the accumulation of autolysosomes. Further studies demonstrated that 163N could not affect the autophagosome-lysosome fusion but could cause lysosome dysfunction. In addition, 163N diminished tumor cell viability and impaired the development of colorectal cancer in vivo. The current study findings indicate that the dual effect inhibitor 163N offers an attractive new anti-cancer drug and compounds having a comb...Continue Reading

References

Jan 10, 2004·Cell Death and Differentiation·T KanzawaS Kondo
Jan 20, 2005·Molecular and Cellular Biology·Patricia BoyaGuido Kroemer
Mar 26, 2008·Autophagy·Maria Høyer-Hansen, Marja Jäättelä
Sep 5, 2008·Molecular Biology of the Cell·Naonobu FujitaTamotsu Yoshimori
Oct 22, 2008·Nature Chemical Biology·Andrew L Hopkins
Jul 8, 2011·Cancer Prevention Research·Hsin-Yi Chen, Eileen White
Aug 2, 2011·Annual Review of Cell and Developmental Biology·Noboru MizushimaYoshinori Ohsumi
Sep 3, 2011·Cell·David C RubinszteinGuido Kroemer
Oct 5, 2011·Critical Reviews in Eukaryotic Gene Expression·Che-Pei KungMaureen Murphy
Apr 27, 2012·Nature Reviews. Cancer·Eileen White
May 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Quentin McAfeeRavi K Amaravadi
Jun 2, 2012·Autophagy·Zhong-Qiu YuZhiping Xie
Jan 5, 2013·Cancer Research·Tomonori KimuraYoshitaka Isaka
Jul 6, 2014·Autophagy·Pei-Feng LiuChih-Wen Shu
Sep 24, 2015·Cancer Management and Research·Bulent Ozpolat, Doris M Benbrook
Apr 14, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Federica PratiMaria Laura Bolognesi
May 25, 2016·Developmental Cell·Megan L GoodallAndrew Thorburn
Aug 25, 2016·Oncotarget·Svetlana BortnikSharon M Gorski
Aug 27, 2016·ACS Medicinal Chemistry Letters·Zongxing QiuGuozhi Tang
Sep 25, 2016·Genes & Development·Ravi AmaravadiEileen White
Oct 14, 2016·European Journal of Medicinal Chemistry·Ziwei ChenRongbiao Pi
Jan 13, 2017·Nature·Nadja S KathederTor Erik Rusten
Nov 24, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Pei-Feng LiuChih-Wen Shu
Mar 7, 2018·Archives of Biochemistry and Biophysics·Jiaqi ChuMin Li
Dec 21, 2018·World Journal of Clinical Cases·Marco VacanteAntonio Biondi

❮ Previous
Next ❯

Citations

Oct 21, 2020·European Journal of Medicinal Chemistry·Gaoxia YangJie Liu
Sep 4, 2021·Frontiers in Oncology·Bo-Zong ShaoEn-Qiang Linghu
Oct 31, 2021·Cellular and Molecular Life Sciences : CMLS·Kewal Kumar MahapatraSujit Kumar Bhutia

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence
xenograft
transmission electron microscopy
transfection
Knockout
PCR
fluorescence microscopy
Assay

Software Mentioned

GraphPad Prism
Graphpad
MOE
PyMOL

Related Concepts

Related Feeds

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Related Papers

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Pei-Feng LiuChih-Wen Shu
© 2022 Meta ULC. All rights reserved